Home » Authors » James Etheridge

Articles by James Etheridge

CareX Raises EUR25M in Second Round To Fund Development

March 10, 2004

By James Etheridge

CareX Brings In EUR25M To Fund Advancement Into Clinical Trials

March 9, 2004

By James Etheridge

CareX Brings In EUR25M To Fund Advancement Into Clinical Trials

March 9, 2004

By James Etheridge

Start-Up Vaxon Seeking EUR7M For Novel Cancer Vaccines

March 3, 2004

By James Etheridge

Start-Up Vaxon Seeking EUR7M For Novel Cancer Vaccines

March 3, 2004

By James Etheridge

ExonHit Raises Additional EUR8.3M; Now Has Cash To Last Into 2006

Feb. 4, 2004

By James Etheridge

ExonHit Raises Additional EUR8.3M; Now Has Cash To Last Into 2006

Feb. 4, 2004

By James Etheridge

ProSkelia, BioXell Enter Alliance To Develop Vitamin 3D Analogues

Jan. 21, 2004

By James Etheridge

Cerep Broadening Services Via $12.9M Acquisition of Hesperion

Jan. 21, 2004

By James Etheridge

ProSkelia, BioXell Enter Alliance To Develop Vitamin 3D Analogues

Jan. 21, 2004

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 4, 2025
NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...